fig5

Figure 5. The mRNA expression of DHX36 (ENSG00000174953) in 33 different cancer types and the matched normal samples (http://gepia2.cancer-pku.cn/#analysis). T: Tumors tissues; N: normal tissues; BRCA: breast invasive carcinoma; CESC: cervical squamous cell carcinoma; COAD: colon adenocarcinoma; DLBC: diffuse large B-cell lymphoma; GBM: glioblastoma multiforme; KIRC: kidney renal clear cell carcinoma; KIRP: kidney renal papillary cell carcinoma; LIHC: liver hepatocellular carcinoma; LUAD: lung adenocarcinoma; LUSC: lung squamous cell carcinoma; OV: ovarian serous cystadenocarcinoma; PAAD: pancreatic adenocarcinoma; READ: rectum adenocarcinoma; SKCM: skin cutaneous melanoma; STAD: stomach adenocarcinoma; TGCT: testicular germ cell tumor; THCA: thyroid carcinoma; THYM: thymoma; UCEC: uterine corpus endometrial carcinoma; UCS: uterine carcinosarcoma; DHX36: DEAH-box helicase 36; ACC: adenoid cystic carcinoma; BLCA: bladder cancer; CHOL: cholangiocarcinoma; ESCA: esophageal carcinoma; HNSC: head and neck squamous cell carcinoma; LAML: acute myeloid leukemia; LGG: low-grade gliomas; MESO: mesothelioma; PCPG: pheochromocytoma and paraganglioma; PRAD: prostate adenocarcinoma; SARC: sarcoma; UVM: uveal Melanoma.